SMART CAMP Symposium on Adoptive Cell Therapy R&D and Translation

In August 2025, SMART’s Critical Analytics for Manufacturing Personalized-Medicine (CAMP) interdisciplinary research group (IRG) hosted an Adoptive Cell Therapy Symposium, co-organised with Esco Aster, a Singapore-founded and headquartered vertically-integrated contract research, development and manufacturing organisation. The half-day event brought together a diverse community of cell therapy manufacturing researchers, clinician-scientists, biotech innovators, investors, and SMART CAMP researchers. Centred on advancing R&D, translation, and innovation in adoptive cell therapy, the symposium showcased the active engagement of SMART-CAMP and the Industry Alignment Fund - Pre-Positioning Programme (IAF-PP), in which CAMP is part of, with academic and industry leaders in the field of cell therapy for impactful research and translational outcomes.

https://smart.mit.edu/post/smart-camp-symposium-on-adoptive-cell-therapy-r-d-and-translation

‍